Related Experiment Video

Updated: Mar 31, 2026

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
14:59

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus

Published on: October 14, 2022

11.7K

Antibiotic prophylaxis for shunt surgery of children: a systematic review

H Xu1, F Hu1, H Hu1

  • 1Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery
|October 27, 2015
PubMed

Insights

Antibiotic prophylaxis significantly reduces infection rates in pediatric shunt surgery. Further multi-center studies are needed to guide optimal use of these antibiotics.

Area of Science:

  • Neurosurgery
  • Infectious Disease Prevention
  • Pediatric Surgery

Background:

  • Intracranial ventricular shunts are crucial for managing hydrocephalus in children.
  • Shunt implantation surgery carries a risk of infection, potentially leading to severe complications.
  • Antibiotic prophylaxis is a common strategy to mitigate surgical site infections.

Purpose of the Study:

  • To evaluate the clinical effectiveness of antibiotic prophylaxis in pediatric patients undergoing intracranial ventricular shunt placement.
  • To determine the impact of prophylactic antibiotics on infection rates in this specific surgical population.

Main Methods:

  • A systematic review and meta-analysis were conducted.
  • Included randomized and non-randomized controlled trials comparing prophylactic antibiotics with placebo or no antibiotics.
  • Analyzed data from seven eligible studies involving 694 participants.

Main Results:

  • Antibiotic prophylaxis demonstrated a significant reduction in infection rates compared to the control group (RR = 0.59, 95% CI = 0.38, 0.90, P < 0.05).
  • The findings indicate a protective effect of prophylactic antibiotics against shunt-related infections.

Conclusions:

  • Current evidence supports the use of antibiotic prophylaxis to significantly lower infection rates in pediatric shunt surgery.
  • Further high-quality, multi-center studies are recommended to establish definitive guidelines for prophylactic antibiotic use in these procedures.
Abstract

Keywords:
Antibiotic prophylaxisMeta-analysisPediatric neurosurgeryShunt infectionSystematic reviewVP shunt

More Related Videos

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats04:12

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats

Published on: March 28, 2025

683

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
374
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
464
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
332
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
732
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
243
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
769